State Of Wisconsin Investment Board Cerus Corp Transaction History

State Of Wisconsin Investment Board

  • $37.8 Billion
  • Q3 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$1.5 - $3.07 $11,730 - $24,007
7,820 Added 55.69%
21,862 $35,000
Q2 2023

Aug 14, 2023
SELL
$1.79 - $2.9 $14,882 - $24,110
-8,314 Reduced 37.19%
14,042 $34,000
Q1 2023

May 15, 2023
BUY
$2.65 - $3.81 $726 - $1,043
274 Added 1.24%
22,356 $66,000
Q4 2022

Feb 14, 2023
SELL
$3.38 - $4.22 $36,808 - $45,955
-10,890 Reduced 33.03%
22,082 $80,000
Q3 2022

Nov 14, 2022
SELL
$3.43 - $5.83 $30,647 - $52,091
-8,935 Reduced 21.32%
32,972 $119,000
Q2 2022

Aug 15, 2022
BUY
$4.41 - $5.69 $184,809 - $238,450
41,907 New
41,907 $222,000

Others Institutions Holding CERS

# of Institutions
156
Shares Held
147M
Call Options Held
84.2K
Put Options Held
55.5K
View Full List

About CERUS CORP

CERS Quotes by TradingView
  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $317M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track State Of Wisconsin Investment Board Portfolio

Follow State Of Wisconsin Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email